Global and China Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2027

Publisher Name :
Date: 27-Oct-2021
No. of pages: 151
Inquire Before Buying

Bipolar Disorder Therapeutics Drugs market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Bipolar Disorder Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Bipolar Disorder Therapeutics Drugs market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- Olanzapine (Zyprexa)

- Quetiapine (Seroquel)

- Risperidone (Risperdal)

- Ariprazole (Abilify)

- Ziprasidone (Geodon)

- Clozapine (Clozaril)

Segment by Application

- lumateperone

- Central Nervous System (CNS) Disorders

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- AstraZeneca

- Allergan

- Bristol-Myers Squibb

- GSK

- Janssen

- AbbVie

- Youdim

- Delpor

- Lundbeck

- Intra-Cellular Therapies

- Novartis Pharmaceuticals Corporation

- Noven Pharmaceuticals

- Otsuka

- Pfizer

- Reviva Pharmaceuticals

Global and China Bipolar Disorder Therapeutics Drugs Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Bipolar Disorder Therapeutics Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type
1.2.2 Olanzapine (Zyprexa)
1.2.3 Quetiapine (Seroquel)
1.2.4 Risperidone (Risperdal)
1.2.5 Ariprazole (Abilify)
1.2.6 Ziprasidone (Geodon)
1.2.7 Clozapine (Clozaril)
1.3 Market by Application
1.3.1 Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application
1.3.2 lumateperone
1.3.3 Central Nervous System (CNS) Disorders
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Bipolar Disorder Therapeutics Drugs Market Size, Estimates and Forecasts
2.1.1 Global Bipolar Disorder Therapeutics Drugs Revenue 2016-2027
2.1.2 Global Bipolar Disorder Therapeutics Drugs Sales 2016-2027
2.2 Global Bipolar Disorder Therapeutics Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Bipolar Disorder Therapeutics Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Bipolar Disorder Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Bipolar Disorder Therapeutics Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2022-2027)
3 Global Bipolar Disorder Therapeutics Drugs Competitor Landscape by Players
3.1 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Sales
3.1.1 Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Revenue
3.2.1 Key Bipolar Disorder Therapeutics Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Bipolar Disorder Therapeutics Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Bipolar Disorder Therapeutics Drugs Revenue in 2020
3.2.6 Global Bipolar Disorder Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Bipolar Disorder Therapeutics Drugs Price by Manufacturers
3.4 Global Bipolar Disorder Therapeutics Drugs Manufacturing Base Distribution, Product Types
3.4.1 Bipolar Disorder Therapeutics Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Type (2016-2021)
4.1.1 Global Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021)
4.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2016-2021)
4.1.3 Bipolar Disorder Therapeutics Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Bipolar Disorder Therapeutics Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Bipolar Disorder Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Bipolar Disorder Therapeutics Drugs Market Size by Application (2016-2021)
5.1.1 Global Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021)
5.1.2 Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2016-2021)
5.1.3 Bipolar Disorder Therapeutics Drugs Price by Application (2016-2021)
5.2 Bipolar Disorder Therapeutics Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Bipolar Disorder Therapeutics Drugs Market Size YoY Growth 2016-2027
6.1.1 China Bipolar Disorder Therapeutics Drugs Sales YoY Growth 2016-2027
6.1.2 China Bipolar Disorder Therapeutics Drugs Revenue YoY Growth 2016-2027
6.1.3 China Bipolar Disorder Therapeutics Drugs Market Share in Global Market 2016-2027
6.2 China Bipolar Disorder Therapeutics Drugs Market Size by Players (International and Local Players)
6.2.1 China Top Bipolar Disorder Therapeutics Drugs Players by Sales (2016-2021)
6.2.2 China Top Bipolar Disorder Therapeutics Drugs Players by Revenue (2016-2021)
6.3 China Bipolar Disorder Therapeutics Drugs Historic Market Review by Type (2016-2021)
6.3.1 China Bipolar Disorder Therapeutics Drugs Sales Market Share by Type (2016-2021)
6.3.2 China Bipolar Disorder Therapeutics Drugs Revenue Market Share by Type (2016-2021)
6.3.3 China Bipolar Disorder Therapeutics Drugs Price by Type (2016-2021)
6.4 China Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2022-2027)
6.4.2 China Bipolar Disorder Therapeutics Drugs Revenue Forecast by Type (2022-2027)
6.4.3 China Bipolar Disorder Therapeutics Drugs Price Forecast by Type (2022-2027)
6.5 China Bipolar Disorder Therapeutics Drugs Historic Market Review by Application (2016-2021)
6.5.1 China Bipolar Disorder Therapeutics Drugs Sales Market Share by Application (2016-2021)
6.5.2 China Bipolar Disorder Therapeutics Drugs Revenue Market Share by Application (2016-2021)
6.5.3 China Bipolar Disorder Therapeutics Drugs Price by Application (2016-2021)
6.6 China Bipolar Disorder Therapeutics Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2022-2027)
6.6.2 China Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2022-2027)
6.6.3 China Bipolar Disorder Therapeutics Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Bipolar Disorder Therapeutics Drugs Market Size YoY Growth 2016-2027
7.2 North America Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
7.2.1 North America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021)
7.2.2 North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Bipolar Disorder Therapeutics Drugs Market Size YoY Growth 2016-2027
9.2 Europe Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
9.2.1 Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021)
9.2.2 Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Bipolar Disorder Therapeutics Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
10.2.1 Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021)
10.2.2 Latin America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 AstraZeneca
12.1.1 AstraZeneca Corporation Information
12.1.2 AstraZeneca Description and Business Overview
12.1.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Products Offered
12.1.5 AstraZeneca Recent Development
12.2 Allergan
12.2.1 Allergan Corporation Information
12.2.2 Allergan Description and Business Overview
12.2.3 Allergan Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Allergan Bipolar Disorder Therapeutics Drugs Products Offered
12.2.5 Allergan Recent Development
12.3 Bristol-Myers Squibb
12.3.1 Bristol-Myers Squibb Corporation Information
12.3.2 Bristol-Myers Squibb Description and Business Overview
12.3.3 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Products Offered
12.3.5 Bristol-Myers Squibb Recent Development
12.4 GSK
12.4.1 GSK Corporation Information
12.4.2 GSK Description and Business Overview
12.4.3 GSK Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 GSK Bipolar Disorder Therapeutics Drugs Products Offered
12.4.5 GSK Recent Development
12.5 Janssen
12.5.1 Janssen Corporation Information
12.5.2 Janssen Description and Business Overview
12.5.3 Janssen Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Janssen Bipolar Disorder Therapeutics Drugs Products Offered
12.5.5 Janssen Recent Development
12.6 AbbVie
12.6.1 AbbVie Corporation Information
12.6.2 AbbVie Description and Business Overview
12.6.3 AbbVie Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 AbbVie Bipolar Disorder Therapeutics Drugs Products Offered
12.6.5 AbbVie Recent Development
12.7 Youdim
12.7.1 Youdim Corporation Information
12.7.2 Youdim Description and Business Overview
12.7.3 Youdim Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Youdim Bipolar Disorder Therapeutics Drugs Products Offered
12.7.5 Youdim Recent Development
12.8 Delpor
12.8.1 Delpor Corporation Information
12.8.2 Delpor Description and Business Overview
12.8.3 Delpor Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Delpor Bipolar Disorder Therapeutics Drugs Products Offered
12.8.5 Delpor Recent Development
12.9 Lundbeck
12.9.1 Lundbeck Corporation Information
12.9.2 Lundbeck Description and Business Overview
12.9.3 Lundbeck Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Lundbeck Bipolar Disorder Therapeutics Drugs Products Offered
12.9.5 Lundbeck Recent Development
12.10 Intra-Cellular Therapies
12.10.1 Intra-Cellular Therapies Corporation Information
12.10.2 Intra-Cellular Therapies Description and Business Overview
12.10.3 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Products Offered
12.10.5 Intra-Cellular Therapies Recent Development
12.11 AstraZeneca
12.11.1 AstraZeneca Corporation Information
12.11.2 AstraZeneca Description and Business Overview
12.11.3 AstraZeneca Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 AstraZeneca Bipolar Disorder Therapeutics Drugs Products Offered
12.11.5 AstraZeneca Recent Development
12.12 Noven Pharmaceuticals
12.12.1 Noven Pharmaceuticals Corporation Information
12.12.2 Noven Pharmaceuticals Description and Business Overview
12.12.3 Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Noven Pharmaceuticals Products Offered
12.12.5 Noven Pharmaceuticals Recent Development
12.13 Otsuka
12.13.1 Otsuka Corporation Information
12.13.2 Otsuka Description and Business Overview
12.13.3 Otsuka Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Otsuka Products Offered
12.13.5 Otsuka Recent Development
12.14 Pfizer
12.14.1 Pfizer Corporation Information
12.14.2 Pfizer Description and Business Overview
12.14.3 Pfizer Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Pfizer Products Offered
12.14.5 Pfizer Recent Development
12.15 Reviva Pharmaceuticals
12.15.1 Reviva Pharmaceuticals Corporation Information
12.15.2 Reviva Pharmaceuticals Description and Business Overview
12.15.3 Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Reviva Pharmaceuticals Products Offered
12.15.5 Reviva Pharmaceuticals Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Bipolar Disorder Therapeutics Drugs Industry Trends
13.2 Bipolar Disorder Therapeutics Drugs Market Drivers
13.3 Bipolar Disorder Therapeutics Drugs Market Challenges
13.4 Bipolar Disorder Therapeutics Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bipolar Disorder Therapeutics Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Olanzapine (Zyprexa)
Table 3. Major Manufacturers of Quetiapine (Seroquel)
Table 4. Major Manufacturers of Risperidone (Risperdal)
Table 5. Major Manufacturers of Ariprazole (Abilify)
Table 6. Major Manufacturers of Ziprasidone (Geodon)
Table 7. Major Manufacturers of Clozapine (Clozaril)
Table 8. Global Bipolar Disorder Therapeutics Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 9. Global Bipolar Disorder Therapeutics Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 10. Global Bipolar Disorder Therapeutics Drugs Sales by Regions (2016-2021) & (K Units)
Table 11. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Regions (2016-2021)
Table 12. Global Bipolar Disorder Therapeutics Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 13. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 14. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Region (2022-2027)
Table 15. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 16. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 17. Global Bipolar Disorder Therapeutics Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 18. Global Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturers (2016-2021)
Table 19. Ranking of Global Top Bipolar Disorder Therapeutics Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 20. Bipolar Disorder Therapeutics Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 21. Bipolar Disorder Therapeutics Drugs Revenue Share by Manufacturers (2016-2021)
Table 22. Global Bipolar Disorder Therapeutics Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 23. Global Bipolar Disorder Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bipolar Disorder Therapeutics Drugs as of 2020)
Table 24. Key Manufacturers Bipolar Disorder Therapeutics Drugs Price (2016-2021) (USD/Unit)
Table 25. Bipolar Disorder Therapeutics Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 26. Manufacturers Bipolar Disorder Therapeutics Drugs Product Type
Table 27. Date of International Manufacturers Enter into Bipolar Disorder Therapeutics Drugs Market
Table 28. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 29. Global Bipolar Disorder Therapeutics Drugs Sales by Type (2016-2021) (K Units)
Table 30. Global Bipolar Disorder Therapeutics Drugs Sales Share by Type (2016-2021)
Table 31. Global Bipolar Disorder Therapeutics Drugs Revenue by Type (2016-2021) (US$ Million)
Table 32. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2016-2021)
Table 33. Bipolar Disorder Therapeutics Drugs Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 34. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 35. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Type (2022-2027)
Table 36. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 37. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 38. Global Bipolar Disorder Therapeutics Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 39. Global Bipolar Disorder Therapeutics Drugs Sales by Application (2016-2021) (K Units)
Table 40. Global Bipolar Disorder Therapeutics Drugs Sales Share by Application (2016-2021)
Table 41. Global Bipolar Disorder Therapeutics Drugs Revenue by Application (2016-2021) (US$ Million)
Table 42. Global Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2016-2021)
Table 43. Bipolar Disorder Therapeutics Drugs Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 44. Global Bipolar Disorder Therapeutics Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 45. Global Bipolar Disorder Therapeutics Drugs Sales Market Share Forecast by Application (2022-2027)
Table 46. Global Bipolar Disorder Therapeutics Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 47. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 48. Global Bipolar Disorder Therapeutics Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 49. China Bipolar Disorder Therapeutics Drugs Sales (K Units) of Key Companies (2016-2021)
Table 50. China Bipolar Disorder Therapeutics Drugs Sales Share by Company (2016-2021)
Table 51. China Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) by Company (2016-2021)
Table 52. China Bipolar Disorder Therapeutics Drugs Revenue Share by Company (2016-2021)
Table 53. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2016-2021)
Table 54. China Bipolar Disorder Therapeutics Drugs Sales Share by Type (2016-2021)
Table 55. China Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 56. China Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Type (2016-2021)
Table 57. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Type (2022-2027)
Table 58. China Bipolar Disorder Therapeutics Drugs Sales Share by Type (2022-2027)
Table 59. China Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 60. China Bipolar Disorder Therapeutics Drugs Revenue Share by Type (2022-2027)
Table 61. China Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Type (2022-2027)
Table 62. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2016-2021)
Table 63. China Bipolar Disorder Therapeutics Drugs Sales Share by Application (2016-2021)
Table 64. China Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 65. China Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Application (2016-2021)
Table 66. China Bipolar Disorder Therapeutics Drugs Sales (K Units) by Application (2022-2027)
Table 67. China Bipolar Disorder Therapeutics Drugs Sales Share by Application (2022-2027)
Table 68. China Bipolar Disorder Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 69. China Bipolar Disorder Therapeutics Drugs Revenue Share by Application (2022-2027)
Table 70. China Bipolar Disorder Therapeutics Drugs Price (USD/Unit) by Application (2022-2027)
Table 71. North America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 72. North America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 73. North America Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 74. North America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 75. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales by Region (2016-2021) & (K Units)
Table 76. Asia Pacific Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)
Table 77. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 78. Asia Pacific Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Table 79. Europe Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 80. Europe Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 81. Europe Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Europe Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 83. Latin America Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 84. Latin America Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 85. Latin Americaa Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Latin America Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 87. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales by Country (2016-2021) & (K Units)
Table 88. Middle East and Africa Bipolar Disorder Therapeutics Drugs Sales Market Share by Country (2016-2021)
Table 89. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 90. Middle East and Africa Bipolar Disorder Therapeutics Drugs Revenue Market Share by Country (2016-2021)
Table 91. AstraZeneca Corporation Information
Table 92. AstraZeneca Description and Business Overview
Table 93. AstraZeneca Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 94. AstraZeneca Bipolar Disorder Therapeutics Drugs Product
Table 95. AstraZeneca Recent Development
Table 96. Allergan Corporation Information
Table 97. Allergan Description and Business Overview
Table 98. Allergan Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 99. Allergan Product
Table 100. Allergan Recent Development
Table 101. Bristol-Myers Squibb Corporation Information
Table 102. Bristol-Myers Squibb Description and Business Overview
Table 103. Bristol-Myers Squibb Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 104. Bristol-Myers Squibb Product
Table 105. Bristol-Myers Squibb Recent Development
Table 106. GSK Corporation Information
Table 107. GSK Description and Business Overview
Table 108. GSK Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 109. GSK Product
Table 110. GSK Recent Development
Table 111. Janssen Corporation Information
Table 112. Janssen Description and Business Overview
Table 113. Janssen Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 114. Janssen Product
Table 115. Janssen Recent Development
Table 116. AbbVie Corporation Information
Table 117. AbbVie Description and Business Overview
Table 118. AbbVie Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 119. AbbVie Product
Table 120. AbbVie Recent Development
Table 121. Youdim Corporation Information
Table 122. Youdim Description and Business Overview
Table 123. Youdim Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 124. Youdim Product
Table 125. Youdim Recent Development
Table 126. Delpor Corporation Information
Table 127. Delpor Description and Business Overview
Table 128. Delpor Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 129. Delpor Product
Table 130. Delpor Recent Development
Table 131. Lundbeck Corporation Information
Table 132. Lundbeck Description and Business Overview
Table 133. Lundbeck Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 134. Lundbeck Product
Table 135. Lundbeck Recent Development
Table 136. Intra-Cellular Therapies Corporation Information
Table 137. Intra-Cellular Therapies Description and Business Overview
Table 138. Intra-Cellular Therapies Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 139. Intra-Cellular Therapies Product
Table 140. Intra-Cellular Therapies Recent Development
Table 141. Novartis Pharmaceuticals Corporation Corporation Information
Table 142. Novartis Pharmaceuticals Corporation Description and Business Overview
Table 143. Novartis Pharmaceuticals Corporation Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 144. Novartis Pharmaceuticals Corporation Product
Table 145. Novartis Pharmaceuticals Corporation Recent Development
Table 146. Noven Pharmaceuticals Corporation Information
Table 147. Noven Pharmaceuticals Description and Business Overview
Table 148. Noven Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 149. Noven Pharmaceuticals Product
Table 150. Noven Pharmaceuticals Recent Development
Table 151. Otsuka Corporation Information
Table 152. Otsuka Description and Business Overview
Table 153. Otsuka Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 154. Otsuka Product
Table 155. Otsuka Recent Development
Table 156. Pfizer Corporation Information
Table 157. Pfizer Description and Business Overview
Table 158. Pfizer Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 159. Pfizer Product
Table 160. Pfizer Recent Development
Table 161. Reviva Pharmaceuticals Corporation Information
Table 162. Reviva Pharmaceuticals Description and Business Overview
Table 163. Reviva Pharmaceuticals Bipolar Disorder Therapeutics Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 164. Reviva Pharmaceuticals Product
Table 165. Reviva Pharmaceuticals Recent Development
Table 166. Bipolar Disorder Therapeutics Drugs Market Trends
Table 167. Bipolar Disorder Therapeutics Drugs Market Drivers
Table 168. Bipolar Disorder Therapeutics Drugs Market Challenges
Table 169. Bipolar Disorder Therapeutics Drugs Market Restraints
Table 170. Bipolar Disorder Therapeutics Drugs Customers List
Table 171. Bipolar Disorder Therapeutics Drugs Distributors List
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Bipolar Disorder Therapeutics Drugs Product Picture
Figure 2. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Olanzapine (Zyprexa) Product Picture
Figure 4. Quetiapine (Seroquel) Product Picture
Figure 5. Risperidone (Risperdal) Product Picture
Figure 6. Ariprazole (Abilify) Product Picture
Figure 7. Ziprasidone (Geodon) Product Picture
Figure 8. Clozapine (Clozaril) Product Picture
Figure 9. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Application in 2020 & 2027
Figure 10. lumateperone
Figure 11. Central Nervous System (CNS) Disorders
Figure 12. Bipolar Disorder Therapeutics Drugs Report Years Considered
Figure 13. Global Bipolar Disorder Therapeutics Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Bipolar Disorder Therapeutics Drugs Market Size 2016-2027 (US$ Million)
Figure 15. Global Bipolar Disorder Therapeutics Drugs Sales 2016-2027 (K Units)
Figure 16. Global Bipolar Disorder Therapeutics Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 17. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region (2016-2021)
Figure 18. Global Bipolar Disorder Therapeutics Drugs Sales Market Share by Region in 2020
Figure 19. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region (2016-2021)
Figure 20. Global Bipolar Disorder Therapeutics Drugs Revenue Market Share by Region in 2020
Figure 21. Global Bipolar Disorder Therapeutics Drugs Sales Share by Manufacturer in 2020
Figure 2
  • Global Divalproex Sodium Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 81
    Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in The brain tissue to stop seizures. Divalproex Sodium is also used to treat The manic phase of bipolar disorder (manic-depressive illness), and helps prevent migraine headaches. This medicine is available only with your doctor's prescription. The global Divalproex Sodium market was valued at US$ 2188.5 million in 2023 and is anticipated to reach US$ 33......
  • Global Divalproex Sodium Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 90
    According to our LPI (LP Information) latest study, the global Divalproex Sodium market size was valued at US$ 2140.9 million in 2023. With growing demand in downstream market, the Divalproex Sodium is forecast to a readjusted size of US$ 3312 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Divalproex Sodium market. Divalproex Sodium are expected to show stable growth in the future market. However, product differ......
  • Global Quetiapine Fumarate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Quetiapine Fumarate market size was valued at US$ 156.2 million in 2023. With growing demand in downstream market, the Quetiapine Fumarate is forecast to a readjusted size of US$ 132.9 million by 2030 with a CAGR of -2.3% during review period. The research report highlights the growth potential of the global Quetiapine Fumarate market. Quetiapine Fumarate are expected to show stable growth in the future market. However, produ......
  • Global Clozapine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Clozapine market size was valued at US$ 341.4 million in 2023. With growing demand in downstream market, the Clozapine is forecast to a readjusted size of US$ 463.4 million by 2030 with a CAGR of 4.5% during review period. The research report highlights the growth potential of the global Clozapine market. Clozapine are expected to show stable growth in the future market. However, product differentiation, reducing costs, and s......
  • Global Trazodone Hydrochloride (API) Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 92
    According to our LPI (LP Information) latest study, the global Trazodone Hydrochloride (API) market size was valued at US$ million in 2023. With growing demand in downstream market, the Trazodone Hydrochloride (API) is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Trazodone Hydrochloride (API) market. Trazodone Hydrochloride (API) are expected to show stable growth in the future......
  • Global Trazodone Hydrochloride (API) Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 93
    According to our (Global Info Research) latest study, the global Trazodone Hydrochloride (API) market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Trazodone, a phenylpiperazine-triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety an......
  • Global Divalproex Sodium Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 91
    According to our (Global Info Research) latest study, the global Divalproex Sodium market size was valued at USD 2251.9 million in 2023 and is forecast to a readjusted size of USD 3371.1 million by 2030 with a CAGR of 5.9% during review period. Divalproex Sodium is used to treat certain types of seizures (epilepsy). This medicine is an anticonvulsant that works in the brain tissue to stop seizures. Divalproex Sodium is also used to treat the manic phase of bipolar disorder (manic-d......
  • Global Risperidone Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 93
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Risperidone market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Janssen (Johnson & Johnson) - Ajanta Pharma - Amneal Pharmaceuticals - Aurobindo Pharma - Hikma - Sandoz - Lannett - Tris Pharma - Ap......
  • Global Schizophrenia Therapeutics Market Status and Outlook 2023-2028
    Published: 27-Dec-2023        Price: US 3160 Onwards        Pages: 101
    Schizophrenia is usually treated with an individually tailored combination of talking therapy and medicine. Most people with schizophrenia are treated by community mental health teams (CMHTs). The goal of the CMHT is to provide day-to-day support and treatment while ensuring you have as much independence as possible. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market va......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs